Omar M Aly

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Acute Myeloid Leukemia

Molecular Docking

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Aya Soudi, Onur Bender, İsmail Çelik, Amer Ali Abd El-Hafeez, Rumeysa Dogan, Arzu Atalay, Eslam B Elkaeed, Aisha A Alsfouk, El Shimaa M N Abdelhafez, Omar M Aly, Wolfgang Sippl, Taha Farouk Shehata Ali
Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Aya Soudi, Onur Bender, İsmail Çelik, Amer Ali Abd El-Hafeez, Rumeysa Dogan, Arzu Atalay, Eslam B Elkaeed, Aisha A Alsfouk, El Shimaa M N Abdelhafez, Omar M Aly, Wolfgang Sippl, Taha Farouk Shehata Ali
Discovery and Anticancer Screening of Novel Oxindole-Based Derivative Bearing Pyridyl Group as Potent and Selective Dual FLT3/CDK2 Kinase Inhibitor. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Moamen A Hassanin, Muhamad Mustafa, Mohammad A S Abourehab, Heba A Hassan, Omar M Aly, Eman A M Beshr
Design and Synthesis of New Hydantoin Acetanilide Derivatives as Anti-NSCLC Targeting EGFR L858R/T790M Mutations. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)